Discussion on Drug Supervision and Management from the Perspective of Drug Quality Standards

He Yingmei, Yang Pingrong, Ren Shuling, Xia Peixia, Liu Zhihao

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (12) : 1596-1602.

PDF(983 KB)
PDF(983 KB)
Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (12) : 1596-1602. DOI: 10.16153/j.1002-7777.2018.12.002
Supervision Administration

Discussion on Drug Supervision and Management from the Perspective of Drug Quality Standards

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 32(12): 1596-1602 https://doi.org/10.16153/j.1002-7777.2018.12.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(983 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉